Literature DB >> 27365880

Diffuse large B-cell non-Hodgkin's lymphoma and osteosclerotic myeloma with features of POEMS syndrome.

Kyari Sumayin Ngamdu1, Alireza Torabi1, Nabeel Badri1, Mohammed Teleb1, Sumit Gaur1.   

Abstract

Multiple myeloma is a clonal hematopoietic neoplasm characterized by the proliferation of malignant plasma cells and associated end-organ damage, most notably lytic lesions in the bones. Osteosclerotic myeloma is an unusual variant of the disease in which the skeletal involvement is characterized by sclerotic lesions instead of classical lytic lesions. The disease can be associated with paraneoplastic symptoms, which have been given the acronym POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes). In addition to clonal plasma cell dyscrasias, some cases of POEMS syndrome are associated with Castleman's disease, and in 11% to 30% of the cases both Castleman's disease and clonal plasma cell proliferation are present. POEMS syndrome has rarely been described in patients with non-Hodgkin's lymphoma.

Entities:  

Year:  2016        PMID: 27365880      PMCID: PMC4900778          DOI: 10.1080/08998280.2016.11929446

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  5 in total

1.  POEMS syndrome with vascular lesions: a role for interleukin-1beta and interleukin-6 increase--a case report.

Authors:  G Bova; A L Pasqui; M Saletti; F Bruni; A Auteri
Journal:  Angiology       Date:  1998-11       Impact factor: 3.619

2.  Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.

Authors:  O Watanabe; I Maruyama; K Arimura; I Kitajima; H Arimura; M Hanatani; K Matsuo; T Arisato; M Osame
Journal:  Muscle Nerve       Date:  1998-11       Impact factor: 3.217

Review 3.  POEMS syndrome: update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2015-09-01       Impact factor: 10.047

4.  Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome.

Authors:  O Watanabe; K Arimura; I Kitajima; M Osame; I Maruyama
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

5.  Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome.

Authors:  Shoko Nakayama; Taiji Yokote; Kichinosuke Kobayashi; Yuji Hirata; Toshikazu Akioka; Takuji Miyoshi; Satoko Oka; Nobuya Hiraoka; Kazuki Iwaki; Ayami Takayama; Takayuki Takubo; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Eur J Haematol       Date:  2010-01-01       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.